Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase 1 13Phase NA 3Phase 1/2 3Phase 3 1Phase 2/3 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3

Conditions

Breast Neoplasms 433Neoplasms 371Prostatic Neoplasms 206Lung Neoplasms 195Colorectal Neoplasms 151Motor Activity 94Uterine Cervical Neoplasms 83Pancreatic Neoplasms 78Carcinoma, Non-Small-Cell Lung 75Head and Neck Neoplasms 74Brain Neoplasms 69Ovarian Neoplasms 65Carcinoma, Hepatocellular 53Colonic Neoplasms 51Rectal Neoplasms 50Neoplasm Metastasis 50Anxiety Disorders 46Precursor Cell Lymphoblastic Leukemia-Lymphoma 45Glioblastoma 43Hematologic Neoplasms 42Depression 41Melanoma 37Glioma 37Disease 37Stomach Neoplasms 35Sarcoma 35Multiple Myeloma 34Pain 32Carcinoma, Renal Cell 32Lymphoma 31

Interventions

Practice Guidelines as Topic 1Methods 1Health Promotion 1Educational Status 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Uveal Melanoma × 90 days × Clear all
NCT06075589 2026-03-19

Psychoeducation for Uveal Melanoma

Jonsson Comprehensive Cancer Center

Phase NA Active not recruiting
108 enrolled
Dermatologic

Uveal Melanoma

NCT06550674 2026-03-19

IGCMU

Centre Jean Perrin

Phase NA Recruiting
50 enrolled
Dermatologic

Uveal Melanoma

NCT07364474 2026-03-11

Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver

Massachusetts General Hospital

Phase NA Recruiting
10 enrolled
Dermatologic

Uveal Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡